Editorial
Calling a “cat a cat”: has the time come to return to “valvular disease” from “structural heart”?
February 19, 2016 | 10.4244/EIJV11I10A219
Accurate procedural assessment of AR – critical for successful TAVI
February 19, 2016 | 10.4244/EIJV11I10A220
Mitral valve-in-ring: the good, the bad, and the ugly
February 19, 2016 | 10.4244/EIJV11I10A221
Percutaneous paravalvular leak closure? Perhaps a glimmer of hope after a long course of marginal success
February 19, 2016 | 10.4244/EIJV11I10A222
EAPCI community news
EAPCI Focus on the Nurses and Allied Professionals (NAPs) Committee
February 19, 2016
Coronary interventions
CLINICAL RESEARCH
Paclitaxel-coated balloon catheter compared with drug-eluting stent for drug-eluting stent restenosis in routine clinical practice February 19, 2016 | 10.4244/EIJY15M02_09
SHORT REPORT
Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry February 19, 2016 | 10.4244/EIJY15M03_08
CLINICAL RESEARCH
Coronary microvascular function in patients with type 2 diabetes mellitus February 19, 2016 | 10.4244/EIJY15M03_09
CLINICAL RESEARCH
Outcome with invasive versus medical treatment of stable coronary artery disease: influence of perfusion defect size, ischaemia, and ejection fraction February 19, 2016 | 10.4244/EIJV11I10A226
IMAGE IN CARDIOLOGY
Acute LAD occlusion by calcified plaque embolisation from the ascending aorta after contralateral LCA angiography February 19, 2016 | 10.4244/EIJV11I10A227
Interventions for valvular disease and heart failure
CLINICAL RESEARCH
Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up February 19, 2016 | 10.4244/EIJY15M09_01
CLINICAL RESEARCH
Feasibility and safety of balloon-expandable transcatheter aortic valve implantation with moderate or without predilatation February 19, 2016 | 10.4244/EIJV11I10A229
CLINICAL RESEARCH
Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis February 19, 2016 | 10.4244/EIJY15M11_04
CLINICAL RESEARCH
First-in-man transcatheter mitral valve-in-ring implantation with a repositionable and retrievable aortic valve prosthesis February 19, 2016 | 10.4244/EIJY15M11_02
CLINICAL RESEARCH
Optimal septum alignment of the Figulla® Flex occluder to the atrial septum in patients with secundum atrial septal defects February 19, 2016 | 10.4244/EIJY14M12_09
CLINICAL RESEARCH
Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry February 19, 2016 | 10.4244/EIJY14M12_12
CLINICAL RESEARCH
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug February 19, 2016 | 10.4244/EIJY15M01_06
CLINICAL RESEARCH
Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation February 19, 2016 | 10.4244/EIJY15M02_05
CLINICAL RESEARCH
Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug February 19, 2016 | 10.4244/EIJY14M10_13
CLINICAL RESEARCH
Early experience of percutaneous paravalvular leak closure using a novel Occlutech occluder February 19, 2016 | 10.4244/EIJV11I10A237
How should i treat?
How should I treat refractory cardiogenic shock in a patient with chronic biventricular heart failure and mitral regurgitation with difficult valve characteristics?
February 19, 2016 | 10.4244/EIJV11I10A238